Latest Regulatory Risks News

Biotron Limited has launched a $1.5 million non-renounceable rights issue to fund its strategic acquisition of Sedarex Limited and support ongoing drug development programs. The capital raise follows shareholder approval and aims to diversify Biotron’s portfolio with a next-generation general anaesthetic.

Genmin Limited has launched a A$25.7 million equity raising to advance its Baniaka iron ore project in Gabon, aiming for a final investment decision by mid-2026. The raise includes strategic collaboration with PowerChina and offers attaching options to investors.

Smart Parking Limited has delivered record FY25 results, driven by strong organic growth and strategic acquisitions including its entry into the US market with Peak Parking. The company is targeting 3,000 ANPR sites globally by 2028, leveraging proprietary AI technology and a capital-light model.

Paladin Energy reported a reduced net loss of US$9.9 million for Q1 FY2026 and completed a significant A$300 million equity raise to fund key uranium projects. The company also faces shareholder class actions alleging misleading production guidance.

Block, Inc. reported robust Q3 2025 results, driven by strong Cash App and Square performance, and raised its full-year guidance. The company’s AI innovations and expanding BNPL offerings are key growth engines.

Infini Resources Limited has launched a non-renounceable pro-rata entitlement offer to raise approximately A$533,000 through Loyalty Options, alongside a separate allocation of 6 million options to its Joint Lead Managers. The capital raise aims to support ongoing exploration activities amid a complex risk landscape.

Sarama Resources has formally filed a US$242 million damages claim against Burkina Faso following the expropriation of its Tankoro 2 Exploration Permit, marking a pivotal step in its international arbitration process.

Aquirian Limited has completed a strategic review of its Wubin Energetics Precinct and entered a framework agreement with Hongda Civil Blasting Group to establish a joint venture for an automated electronic detonator facility in Western Australia.

Noble Helium advances its North Rukwa helium project with a confirmed five-hole drilling campaign and a significant resource upgrade, backed by leadership changes and shareholder funding.

Cleo Diagnostics has secured positive FDA feedback and nearly 1,600 biobank samples, accelerating its ovarian cancer blood test development ahead of a planned 2026 U.S. market entry.

NGX Limited progresses its Malingunde graphite project with key technical studies and downstream qualification, while advancing uranium exploration in Namibia. Market dynamics and regulatory shifts position NGX favorably in the clean energy minerals sector.

Galan Lithium has completed a $20 million placement and secured Argentine government incentives, advancing its Hombre Muerto West lithium project toward first production in early 2026.